Stay updated on Pembro/Carbo/Taxol in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembro/Carbo/Taxol in Endometrial Cancer Clinical Trial page.

Latest updates to the Pembro/Carbo/Taxol in Endometrial Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThis update only changes the page revision from v3.3.3 to v3.3.4 with no substantive changes to the study details or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check31 days agoChange Detected- Added a consolidated Locations section listing the study sites by state (Arizona, Illinois, Indiana, Iowa, Minnesota) and updated the page revision to v3.3.3. Removed the separate state-location entries and the HHS Vulnerability Disclosure link.SummaryDifference0.6%

- Check52 days agoChange DetectedThe page now shows Revision: v3.3.2, replacing the previous Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision: v3.3.1 added; v3.2.0 removed, updating the study documents. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check67 days agoChange DetectedThe government funding lapse notice banner was removed from the page. The study details, interventions, locations, and eligibility criteria remain unchanged.SummaryDifference0.3%

- Check81 days agoChange DetectedNo significant changes detected between the old and new screenshots; the page content remains the same.SummaryDifference0.4%

Stay in the know with updates to Pembro/Carbo/Taxol in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembro/Carbo/Taxol in Endometrial Cancer Clinical Trial page.